Nisa Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.87K Sell
27
-203
-88% -$21.5K ﹤0.01% 2539
2025
Q1
$28.6K Hold
230
﹤0.01% 1754
2024
Q4
$28.3K Sell
230
-15
-6% -$1.85K ﹤0.01% 1831
2024
Q3
$27.3K Sell
245
-4
-2% -$446 ﹤0.01% 1809
2024
Q2
$26.6K Sell
249
-14,037
-98% -$1.5M ﹤0.01% 1843
2024
Q1
$1.72M Buy
14,286
+5,126
+56% +$617K 0.01% 732
2023
Q4
$1.13M Buy
9,160
+9,098
+14,674% +$1.12M 0.01% 818
2023
Q3
$8.03K Sell
62
-15
-19% -$1.94K ﹤0.01% 2220
2023
Q2
$9.55K Sell
77
-9,994
-99% -$1.24M ﹤0.01% 2266
2023
Q1
$1.47M Hold
10,071
0.01% 742
2022
Q4
$1.6M Buy
10,071
+10,000
+14,085% +$1.59M 0.01% 792
2022
Q3
$9K Sell
71
-1,129
-94% -$143K ﹤0.01% 2211
2022
Q2
$187K Hold
1,200
﹤0.01% 1327
2022
Q1
$187K Sell
1,200
-2,471
-67% -$385K ﹤0.01% 1405
2021
Q4
$510K Sell
3,671
-34,439
-90% -$4.78M ﹤0.01% 1007
2021
Q3
$4.96K Sell
38,110
-20,636
-35% -$2.69K 0.03% 441
2021
Q2
$10.4K Buy
58,746
+36,315
+162% +$6.45K 0.07% 270
2021
Q1
$3.69K Sell
22,431
-27,139
-55% -$4.46K 0.02% 536
2020
Q4
$8.18M Buy
49,570
+32,487
+190% +$5.36M 0.05% 310
2020
Q3
$2.44M Sell
17,083
-8,541
-33% -$1.22M 0.02% 552
2020
Q2
$2.83M Sell
25,624
-3,296
-11% -$364K 0.03% 489
2020
Q1
$2.88M Buy
28,920
+14,448
+100% +$1.44M 0.03% 429
2019
Q4
$2.16M Sell
14,472
-8,906
-38% -$1.33M 0.02% 616
2019
Q3
$3M Buy
23,378
+10,606
+83% +$1.36M 0.03% 513
2019
Q2
$1.82M Sell
12,772
-8,442
-40% -$1.2M 0.02% 668
2019
Q1
$3.03M Buy
21,214
+7,018
+49% +$1M 0.03% 493
2018
Q4
$1.76M Sell
14,196
-8,959
-39% -$1.11M 0.02% 602
2018
Q3
$3.89M Buy
23,155
+17,955
+345% +$3.02M 0.04% 435
2018
Q2
$896K Hold
5,200
0.01% 876
2018
Q1
$785K Sell
5,200
-1,000
-16% -$151K 0.01% 899
2017
Q4
$835K Sell
6,200
-200
-3% -$26.9K 0.01% 887
2017
Q3
$936K Buy
6,400
+6,200
+3,100% +$907K 0.01% 840
2017
Q2
$31K Sell
200
-800
-80% -$124K ﹤0.01% 1439
2017
Q1
$145K Hold
1,000
﹤0.01% 1304
2016
Q4
$109K Sell
1,000
-10,268
-91% -$1.12M ﹤0.01% 1335
2016
Q3
$1.37M Buy
11,268
+544
+5% +$66.1K 0.02% 688
2016
Q2
$1.52M Buy
10,724
+5,624
+110% +$795K 0.02% 632
2016
Q1
$666K Buy
+5,100
New +$666K 0.01% 899